Spirulina Guru markSpirulina.Guru

Mechanistic Pathways · 9 min read · 2027-11-04

Spirulina and TGF-β Signaling

The master cytokine of fibrosis. Block it pharmacologically and you risk autoimmunity. Modulate it gently with phycocyanin and you spare both.

spirulina and tgf beta fibrosis pathway

TGF-β-SMAD Cascade

TGF-β binds TGFβRI/II heterotetramer, phosphorylating SMAD2/3 which complex with SMAD4 and translocate to nucleus, driving fibrotic gene expression (collagen, fibronectin, CTGF, α-SMA). Persistent TGF-β activation drives liver, kidney, lung, and skin fibrosis. SMAD7 is the endogenous inhibitor.

Phycocyanin Dampens TGF-β

Spirulina's reduced inflammation lowers TGF-β release; phycocyanin upregulates SMAD7 expression, providing dual brake. Animal models show 25-40% reduction in collagen deposition in liver, kidney, and lung fibrosis with phycocyanin pretreatment.

Conclusion

Spirulina engages anti-fibrotic mechanisms through TGF-β reduction and SMAD7 upregulation, with relevance across NAFLD-NASH-cirrhosis, diabetic nephropathy, pulmonary fibrosis, and skin scarring. Pharmacologic TGF-β blockers face systemic autoimmunity concerns; spirulina's milder modulation provides safer chronic intervention.

Members only · science

Create a free account to continue reading

This is one of 1,000+ mechanistic deep-dives available to members. Free to join — independent, evidence-honest, no paid placements.

  • Full access to all mechanistic pathway articles
  • Detailed brand reviews and dosing protocols
  • Clinical evidence updates and new posts first
  • Free — no credit card required

Spirulina Guru is independent — no paid placements, no MLM partnerships, no industry sponsorships.

Community

14,000+ spirulina enthusiasts — join the conversation

Spirulina Love is the longest-running organic spirulina group on Facebook, moderated by Yunus since 2007. Ask questions, share experiences, and discover which brands members actually trust.

Join Spirulina Love